# FDA Inspection 1181427 - Meiji Seika Pharma Co., Ltd. - Gifu Plant - September 02, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/meiji-seika-pharma-co-ltd-gifu-plant/de7e26f1-474d-4129-be7e-16a1938e9de0
Source feed: FDA_Inspections

> FDA Inspection 1181427 for Meiji Seika Pharma Co., Ltd. - Gifu Plant on September 02, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181427
- Company Name: Meiji Seika Pharma Co., Ltd. - Gifu Plant
- Inspection Date: 2022-09-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 964799 - 2016-03-04](https://www.globalkeysolutions.net/records/fda_inspections/meiji-seika-pharma-co-ltd-gifu-plant/7a58d362-e783-4799-8944-04e56d46a2f7)
- [FDA Inspection 815023 - 2012-12-07](https://www.globalkeysolutions.net/records/fda_inspections/meiji-seika-pharma-co-ltd-gifu-plant/0e91ff89-c3b1-4492-bab3-bfc1136a6a51)

Company: https://www.globalkeysolutions.net/companies/meiji-seika-pharma-co-ltd-gifu-plant/a0899cb0-5341-4138-a818-189061dae9ad

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c